Literature DB >> 16037818

Arf-dependent regulation of Pdgf signaling in perivascular cells in the developing mouse eye.

Ricardo L A Silva1, J Derek Thornton, Amy C Martin, Jerold E Rehg, David Bertwistle, Frederique Zindy, Stephen X Skapek.   

Abstract

We have established that the Arf tumor suppressor gene regulates mural cell biology in the hyaloid vascular system (HVS) of the developing eye. In the absence of Arf, perivascular cells accumulate within the HVS and prevent its involution. We now demonstrate that mural cell accumulation evident at embryonic day (E) 13.5 in Arf(-/-) mice was driven by excess proliferation at E12.5, when Arf expression was detectable in vitreous pericyte-like cells. Their expression of Arf overlapped with Pdgf receptor beta (Pdgfrbeta), which is essential for pericyte accumulation in the mouse. In cultured cells, p19Arf decreased Pdgfrbeta and blocked Pdgf-B-driven proliferation independently of Mdm2 and p53. The presence of a normal Arf allele correlated with decreased Pdgfrbeta in the embryonic vitreous. Pdgfrbeta was required for vitreous cell accumulation in the absence of Arf. Our findings demonstrate a novel, p53- and Mdm2-independent function for p19Arf. Instead of solely sensing excessive mitogenic stimuli, developmental cues induce Arf to block Pdgfrbeta-dependent signals and prevent the accumulation of perivascular cells selectively in a vascular bed destined to regress.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16037818      PMCID: PMC1182246          DOI: 10.1038/sj.emboj.7600751

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  50 in total

1.  High frequency of persistent hyperplastic primary vitreous and cataracts in p53-deficient mice.

Authors:  M B Reichel; R R Ali; F D'Esposito; A R Clarke; P J Luthert; S S Bhattacharya; D M Hunt
Journal:  Cell Death Differ       Date:  1998-02       Impact factor: 15.828

Review 2.  Tumor surveillance via the ARF-p53 pathway.

Authors:  C J Sherr
Journal:  Genes Dev       Date:  1998-10-01       Impact factor: 11.361

3.  Regression of vessels in the tunica vasculosa lentis is initiated by coordinated endothelial apoptosis: a role for vascular endothelial growth factor as a survival factor for endothelium.

Authors:  C A Mitchell; W Risau; H C Drexler
Journal:  Dev Dyn       Date:  1998-11       Impact factor: 3.780

4.  p19ARF links the tumour suppressor p53 to Ras.

Authors:  I Palmero; C Pantoja; M Serrano
Journal:  Nature       Date:  1998-09-10       Impact factor: 49.962

5.  Two p16 (CDKN2A) germline mutations in 30 Israeli melanoma families.

Authors:  E Yakobson; P Shemesh; E Azizi; E Winkler; N Lassam; D Hogg; S Brookes; G Peters; M Lotem; A Zlotogorski; M Landau; M Safro; R Shafir; E Friedman; H Peretz
Journal:  Eur J Hum Genet       Date:  2000-08       Impact factor: 4.246

6.  Tumor spectrum in ARF-deficient mice.

Authors:  T Kamijo; S Bodner; E van de Kamp; D H Randle; C J Sherr
Journal:  Cancer Res       Date:  1999-05-01       Impact factor: 12.701

7.  E1A signaling to p53 involves the p19(ARF) tumor suppressor.

Authors:  E de Stanchina; M E McCurrach; F Zindy; S Y Shieh; G Ferbeyre; A V Samuelson; C Prives; M F Roussel; C J Sherr; S W Lowe
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

8.  Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal.

Authors:  L E Benjamin; D Golijanin; A Itin; D Pode; E Keshet
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

9.  Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization.

Authors:  F Zindy; C M Eischen; D H Randle; T Kamijo; J L Cleveland; C J Sherr; M F Roussel
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

10.  A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF.

Authors:  L E Benjamin; I Hemo; E Keshet
Journal:  Development       Date:  1998-05       Impact factor: 6.868

View more
  31 in total

1.  Molecular cloning of the human platelet-derived growth factor receptor beta (PDGFR-beta) promoter and drug targeting of the G-quadruplex-forming region to repress PDGFR-beta expression.

Authors:  Yong Qin; Jessica S Fortin; Denise Tye; Mary Gleason-Guzman; Tracy A Brooks; Laurence H Hurley
Journal:  Biochemistry       Date:  2010-05-18       Impact factor: 3.162

2.  INK4a deletion results in improved kidney regeneration and decreased capillary rarefaction after ischemia-reperfusion injury.

Authors:  David H Lee; Jesse M Wolstein; Basu Pudasaini; Matthew Plotkin
Journal:  Am J Physiol Renal Physiol       Date:  2011-09-28

3.  miR-34a is essential for p19(Arf)-driven cell cycle arrest.

Authors:  Nida Iqbal; Jie Mei; Jing Liu; Stephen X Skapek
Journal:  Cell Cycle       Date:  2014-01-08       Impact factor: 4.534

4.  P14ARF inhibits human glioblastoma-induced angiogenesis by upregulating the expression of TIMP3.

Authors:  Abdessamad Zerrouqi; Beata Pyrzynska; Maria Febbraio; Daniel J Brat; Erwin G Van Meir
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

5.  Formation of persistent hyperplastic primary vitreous in ephrin-A5-/- mice.

Authors:  Alexander I Son; Michal Sheleg; Margaret A Cooper; Yuhai Sun; Norman J Kleiman; Renping Zhou
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-19       Impact factor: 4.799

6.  p18Ink4c and p53 Act as tumor suppressors in cyclin D1-driven primitive neuroectodermal tumor.

Authors:  Raya Saab; Carlos Rodriguez-Galindo; Kelly Matmati; Jerold E Rehg; Shannon H Baumer; Joseph D Khoury; Catherine Billups; Geoffrey Neale; Kathleen J Helton; Stephen X Skapek
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

7.  Isolation and characterization of mammalian cells expressing the Arf promoter during eye development.

Authors:  Nida S Iqbal; Lin Xu; Caitlin C Devitt; Stephen X Skapek
Journal:  Biotechniques       Date:  2014-05-01       Impact factor: 1.993

8.  p19Arf represses platelet-derived growth factor receptor β by transcriptional and posttranscriptional mechanisms.

Authors:  Ryan C Widau; Yanbin Zheng; Caroline Y Sung; Anna Zelivianskaia; Lauren E Roach; Karen M Bachmeyer; Tatiana Abramova; Aurelie Desgardin; Andrew Rosner; John M Cunningham; Stephen X Skapek
Journal:  Mol Cell Biol       Date:  2012-08-20       Impact factor: 4.272

9.  Loss of p19(Arf) facilitates the angiogenic switch and tumor initiation in a multi-stage cancer model via p53-dependent and independent mechanisms.

Authors:  Danielle B Ulanet; Douglas Hanahan
Journal:  PLoS One       Date:  2010-08-27       Impact factor: 3.240

10.  Arf tumor suppressor and miR-205 regulate cell adhesion and formation of extraembryonic endoderm from pluripotent stem cells.

Authors:  Chunliang Li; David Finkelstein; Charles J Sherr
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.